These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3020038)

  • 41. Application of receptor theory provides further evidence for the existence of the epsilon-opioid receptor in rat vas deferens.
    Garzón J; Schulz R; Herz A
    Neuropeptides; 1984 Dec; 5(1-3):101-4. PubMed ID: 6099473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta-endorphin. Synthesis and biological activity of analogs with disulfide bridges.
    Blake J; Helmeste DM; Li CH
    Int J Pept Protein Res; 1985 Jun; 25(6):575-9. PubMed ID: 2993181
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
    Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
    J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation.
    Keller M; Boissard C; Patiny L; Chung NN; Lemieux C; Mutter M; Schiller PW
    J Med Chem; 2001 Nov; 44(23):3896-903. PubMed ID: 11689075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Partial agonistic action of morphine in the rat vas deferens.
    Ishii K; Yamamoto S; Muraki T; Kato R
    Jpn J Pharmacol; 1981 Dec; 31(6):905-9. PubMed ID: 6278185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of an amphiphilic helical structure in beta-endorphin through the design, synthesis, and study of model peptides.
    Taylor JW; Miller RJ; Kaiser ET
    J Biol Chem; 1983 Apr; 258(7):4464-71. PubMed ID: 6300088
    [No Abstract]   [Full Text] [Related]  

  • 47. Contribution of the amino terminal tyrosine to the interaction of gamma-endorphin with opiate receptors.
    Puett D; Hammonds RG; Ling N
    Peptides; 1982; 3(1):87-9. PubMed ID: 6176977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative study on the effect of morphine and the opioid-like peptides in the vas deferens of rodents: species and strain differences, evidence for multiple opiate receptors.
    Huidobro-Toro JP; Way EL
    Life Sci; 1981 Mar; 28(12):1331-6. PubMed ID: 6264244
    [No Abstract]   [Full Text] [Related]  

  • 49. Structure-activity relationships of cyclic beta-casomorphin-5 analogues.
    Schmidt R; Neubert K; Barth A; Liebmann C; Schnittler M; Chung NN; Schiller PW
    Peptides; 1991; 12(6):1175-80. PubMed ID: 1667685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary structure and morphine-like activity of human beta-endorphin.
    Dragon N; Seidah NG; Lis M; Routhier R; Chrétien M
    Can J Biochem; 1977 Jun; 55(6):666-70. PubMed ID: 195688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beta-Endorphin. Synthesis and radioreceptor-binding activity of the ostrich hormone.
    Yamashiro D; Hammonds RG; Li CH
    Int J Pept Protein Res; 1982 Mar; 19(3):251-3. PubMed ID: 6288586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human beta-endorphin. Synthesis and biological activity of analogs with modifications in residue positions 3, 4 or 5.
    Yamashiro D; Westphal M; Li CH
    Int J Pept Protein Res; 1984 Nov; 24(5):516-9. PubMed ID: 6097555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions between morphine and the opioid-like peptides in the rat vas deferens.
    Huidobro F; Huidobro-Toro JP; Miranda H
    Br J Pharmacol; 1980 Dec; 70(4):519-25. PubMed ID: 6258678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human beta-endorphin. Synthesis and biological activity of analogs with modification in residue positions 8, 27, and 9 or 11.
    Yamashiro D; Li CH; Westphal M
    Int J Pept Protein Res; 1984 Nov; 24(5):520-4. PubMed ID: 6097556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assays.
    Bonner GG; Davis P; Stropova D; Edsall S; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 2000 Feb; 43(4):569-80. PubMed ID: 10691683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
    Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
    Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Binding characteristics of dermorphin, and [dermorphin1-7]-beta c-endorphin in rat brain membranes.
    Westphal M; Hammonds RG; Li CH
    Peptides; 1985; 6(1):149-52. PubMed ID: 2986079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beta-endorphin. Receptor binding and peripheral opioid activities of [Gln8]-, [Trp27]-, and [Tyr31]-analogs.
    Ho CL; Ko JL; Li CH
    Int J Pept Protein Res; 1988 Jul; 32(1):74-8. PubMed ID: 2851563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro pharmacology of the opioid peptides, enkephalins and endorphins.
    Waterfield AA; Smokcum RW; Hughes J; Kosterlitz HW; Henderson G
    Eur J Pharmacol; 1977 May; 43(2):107-16. PubMed ID: 17538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of N-terminal acetylation and C-terminal proteolysis on the analgesic activity of beta-endorphin.
    Deakin JF; Doströvsky JO; Smyth DG
    Biochem J; 1980 Sep; 189(3):501-6. PubMed ID: 6260082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.